Sridharan Natalie, Williams Abimbola O, Rojanasarot Sirikan, Anderson Nicholas, Wifler Wendy, Jaff Michael R, Chaer Rabih
UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania.
Boston Scientific, Marlborough, Massachusetts.
J Vasc Interv Radiol. 2023 Feb;34(2):164-172.e2. doi: 10.1016/j.jvir.2022.10.012. Epub 2022 Oct 18.
To examine the frequency, costs, and cost influencers of inferior vena cava filters (IVCFs) placements and retrievals among a national sample of patients using Medicare data.
This retrospective cohort study used the U.S. Medicare 100% database, a nationally representative sample of all U.S. patients aged ≥65 years, from 2014 through 2020. Procedures and clinical characteristics were identified from the diagnosis and procedure codes on Medicare claims. Beneficiaries aged ≥65 years with newly diagnosed venous thromboembolism (VTE) were identified and followed to obtain data on IVCF placements and retrievals. Data on the costs of the index IVCF procedures and any subsequent IVCF placements and retrievals were obtained. Multivariate models were used to estimate the impact of patient and clinical characteristics on costs.
Among 501,216 patients with newly diagnosed VTE, 4,995 (1%) received an IVCF placement; of these, 1,215 (24.3%) had a retrieval procedure. Beneficiaries with IVCF placements and retrievals differed from a demographic and clinical perspective than from those without. Costs varied by the site of service, VTE acuity, and VTE type. Cost influencers included age, race, census region, service location, and VTE type.
IVCF placement costs were driven by baseline patient characteristics (age, race, geographic residence, acute VTE diagnosis, and inpatient site of service), whereas retrieval costs were driven by age and deep vein thrombosis diagnosis. Strategies to mitigate the retrieval costs or the need to retrieve IVCFs may reduce the overall cost burden of IVCFs.
利用医疗保险数据,在全国患者样本中研究下腔静脉滤器(IVCF)置入和取出的频率、成本及成本影响因素。
这项回顾性队列研究使用了美国医疗保险100%数据库,该数据库是2014年至2020年期间美国所有年龄≥65岁患者的全国代表性样本。从医疗保险理赔的诊断和程序代码中确定程序和临床特征。确定年龄≥65岁且新诊断为静脉血栓栓塞症(VTE)的受益人,并对其进行随访,以获取IVCF置入和取出的数据。获取首次IVCF程序以及任何后续IVCF置入和取出的成本数据。使用多变量模型估计患者和临床特征对成本的影响。
在501,216例新诊断为VTE的患者中,4,995例(1%)接受了IVCF置入;其中,1,215例(24.3%)进行了取出程序。接受IVCF置入和取出的受益人与未接受的受益人在人口统计学和临床方面存在差异。成本因服务地点、VTE严重程度和VTE类型而异。成本影响因素包括年龄、种族、人口普查区域、服务地点和VTE类型。
IVCF置入成本受患者基线特征(年龄、种族、地理居住、急性VTE诊断和住院服务地点)驱动,而取出成本受年龄和深静脉血栓形成诊断驱动。降低取出成本或减少IVCF取出需求的策略可能会减轻IVCF的总体成本负担。